Medication safety considerations for compounded injectable vitamins
Small changes such as portion size or the type of cooking oil used can compound into accelerated results
Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and is not recommended during pregnancy or breastfeeding
This upgrades the therapeutic goal from weight loss to comprehensive reproductive health management. 6.5 Preconception pathway: smooth transition from metabolic optimization to conception The goal of periconception management is not merely to achieve the lowest possible weight, but to ensure the patient enters a window of relative weight and metabolic stability after an adequate washout before attempting conception
Clinical trials lasting 68 weeks showed that participants on semaglutide maintained significant weight loss throughout the treatment period, with continued improvements in metabolic markers including blood sugar, blood pressure, and cholesterol levels
The consensus statement does suggest, however, that DPP-4 inhibitors may be appropriate in select populations based on concerns associated with weight gain and hypoglycemia, similar to the AACE and ACE recommendations